REGN vs GILD
Regeneron Pharmaceuticals vs Gilead Sciences — AI-powered side-by-side comparison
| Metric | REGN | GILD |
|---|---|---|
| AI Score | 65 | 66 |
| Price | $664.56 | $129.81 |
| P/E Ratio | 15.80× | 18.11× |
| ROE | 14.3% | 42.2% |
| Revenue Growth YoY | 5.9% | 3.5% |
| Gross Margin | 85.7% | 79.3% |
| Debt / Equity | 0.09× | 1.10× |
| Dividend Yield | 0.6% | 2.4% |
| RSI (14) | 65.3 | 49.2 |
| Beta | 0.2076 | 0.3411 |
| Expected Upside | +12.5% | +21.1% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
REGN Full Analysis
GILD Full Analysis